Clinical and prognostic relevance of the Kiel classification of non‐Hodgkin lymphomas results of a prospective multicenter study by the Kiel Lymphoma Study Group

Brittinger, G.; Bartels, H.; Common, Harold; Dühmke, E.; Fülle, H.H.; Gunzer, U.; Gyenes, T.; Heinz, R.; König, E; Meusers, P.; Paukstat, M.; Pralle, H.; Theml, H.; Köpcke, Wolfgang; Thieme, C; Zwingers, T.; Musshoff, K.; Stacher, A; Brücher, H; Herrmann, F.; D. Ludwig, W.; Pribilla, W; Burger‐Schüler, A.; W. Löhr, G.; Gremmel, H; Oertel, Joachim; Gerhartz, H.; Koeppen, K.‐M.; Boll, Irene; Huhn, D.; Binder, Thomas; Schoengen, A.; Nowicki, L.; Pees, H.W.; G. Scheurlen, P.; Leopold, H.; Wannenmacher, M.; Schmidt, M.; Löffler, H.; Michlmayr, G.; Thiel, E.; Zettel, R.; Rühl, U; Wilke, H.; Schwarze, E.‐W.; Stein, H.; Feller, A.C.; Lennert, K.; LYMPHOMA STUDY GROUP, KIEL

doi:10.1002/hon.2900020306

Public

Clinical and prognostic relevance of the Kiel classification of non‐Hodgkin lymphomas results of a prospective multicenter study by the Kiel Lymphoma Study Group

Published in Hematological Oncology • Jul 1, 1984

Authors:

G. Brittinger

H. Bartels

Harold Common

Abstract

Clinical and prognostic relevance of the Kiel classification of non-Hodgkin lymphomas (NHL) was investigated in 1127 patients entering a prospective multicenter observation study. Survival of the 782 (69.4 per cent) patients with low-grade malignant NHL (lymphocytic lymphomas, predominantly B-CLL, L...

Subject

Lymphoma

Medicine

Lymphoblastic lymphoma

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!